RU93051177A - CRYSTALLINE CARBAPENEME DERIVATIVE, METHOD FOR PRODUCING, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING AND / OR PREVENTION - Google Patents

CRYSTALLINE CARBAPENEME DERIVATIVE, METHOD FOR PRODUCING, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING AND / OR PREVENTION

Info

Publication number
RU93051177A
RU93051177A RU93051177/04A RU93051177A RU93051177A RU 93051177 A RU93051177 A RU 93051177A RU 93051177/04 A RU93051177/04 A RU 93051177/04A RU 93051177 A RU93051177 A RU 93051177A RU 93051177 A RU93051177 A RU 93051177A
Authority
RU
Russia
Prior art keywords
crystalline
carbapeneme
derivative
prevention
treating
Prior art date
Application number
RU93051177/04A
Other languages
Russian (ru)
Other versions
RU2090567C1 (en
Inventor
Кавамото Исао
Мияути Масао
Эндо Рокуро
Original Assignee
Санкио Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санкио Компани Лимитед filed Critical Санкио Компани Лимитед
Publication of RU93051177A publication Critical patent/RU93051177A/en
Application granted granted Critical
Publication of RU2090567C1 publication Critical patent/RU2090567C1/en

Links

Claims (1)

Предлагается стабильная при хранении кристаллическая форма пивалоилоксиметилового эфира производного карбапенема, известного как (1R, 5S, 6S)-2-[(4R)-2-оксо-4-пирролидинилтио] -6-[(1R)-1-гидроксиэтил] -1- метил-1-карбапен-2-ем-3-карбоновая кислота.A storage crystalline crystalline form of pivaloyloxymethyl ether of a carbapenem derivative known as (1R, 5S, 6S) -2 - [(4R) -2-oxo-4-pyrrolidinylthio] -6 - [(1R) -1-hydroxyethyl] -1 - methyl-1-carbapen-2-em-3-carboxylic acid.
RU9393051177A 1992-11-17 1993-11-16 Crystalline pivaloylhydroxymethyl-(1r, 5s, 6s)-[(4r)-2-oxo-4--pyrrolidinylthio]-6-[(1r)-1-hydroxyethyl]-1-methyl-1-carbape--ne-2-eme-3-carboxylate and method of its synthesis RU2090567C1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4-306884 1992-11-17
JP30688492 1992-11-17
JP4306884 1992-11-17
JP5170267 1993-07-09

Publications (2)

Publication Number Publication Date
RU93051177A true RU93051177A (en) 1996-12-27
RU2090567C1 RU2090567C1 (en) 1997-09-20

Family

ID=17962415

Family Applications (1)

Application Number Title Priority Date Filing Date
RU9393051177A RU2090567C1 (en) 1992-11-17 1993-11-16 Crystalline pivaloylhydroxymethyl-(1r, 5s, 6s)-[(4r)-2-oxo-4--pyrrolidinylthio]-6-[(1r)-1-hydroxyethyl]-1-methyl-1-carbape--ne-2-eme-3-carboxylate and method of its synthesis

Country Status (3)

Country Link
HU (1) HU211964A9 (en)
RU (1) RU2090567C1 (en)
ZA (1) ZA938438B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2530900C2 (en) * 2007-01-12 2014-10-20 Новартис Аг Method of obtaining 5-biphenyl-4-amino-2-methylpentanoic acid

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022841B2 (en) * 2001-09-26 2006-04-04 Merck & Co. Inc. Process for making carbapenem compounds
CZ23088U1 (en) 2004-03-25 2011-12-19 Astellas Pharma Inc. Composition of solifenacin or salt thereof for use in solid formulation
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2530900C2 (en) * 2007-01-12 2014-10-20 Новартис Аг Method of obtaining 5-biphenyl-4-amino-2-methylpentanoic acid

Similar Documents

Publication Publication Date Title
FI103576B1 (en) A process for the preparation of a crystalline carbapenem derivative useful as a medicament
ES8202015A1 (en) Penem-3-carboxylic acid derivatives, their preparation and use
RU93051177A (en) CRYSTALLINE CARBAPENEME DERIVATIVE, METHOD FOR PRODUCING, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING AND / OR PREVENTION
NZ332453A (en) (1R,5S,6S)-6-[(1R)-1-hydroxyethyl]-1-methyl-2-[(2S,4S)-2-[(3R)-3-methylaminomethylpyrrolidin-1-ylcarbonyl]pyrrolidin-4-ylthio]-1-carbapen-2-em-3-carboxylic acid for the prevention or treatment of bacterial infections
RU98119310A (en) 1-METHYL CARBAPENEM OR ITS PHARMACOLOGICALLY ACCEPTABLE SALTS OR DERIVATIVES, COMPOSITION, METHOD OF PREVENTION OR TREATMENT OF BACTERIAL INFECTIONS
HU894594D0 (en) Crystalline (5r,6s)-2-(carbomyl-oxy-methyl)-6-[(1r)-hydroxi-ethyl]-2-penem-carboxylic acid and pharmaceutical preparatives containing this compounds
DE3880660D1 (en) In 2-stellung substituierte (1r,5s,6s)-2-thio-6-((r)-1-hydroxyethyl)-1-methyl-carbapenem-carbonsaeure-derivate.
IE57163B1 (en) Novel penem compounds,pharmaceutical compositions containing them,processes for their preparation
CZ230195A3 (en) Process for preparing condensed carbapenem derivative and intermediate for preparing thereof
TH14970EX (en) Carbaphenam derivatives, which are crystals.
TH10195B (en) Carbaphenam derivatives, which are crystals.
CO4750657A1 (en) NEW COMPOUNDS
ZA9114B (en) Process for preparing(1r,5s,6s)-2-((6,7-dihydro-5h-pyrazolo(1,2-a)(1,2,4)triazolium-6-yl))thio-6-((r)-1-hydroxyethyl)-1-methyl-carbapenem-3-carboxylate and starting materials thereof